INKT
MiNK Therapeutics, Inc.
Key Financials
Operating Income
$-12642136
↓ 12.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/2/2026 | View on SEC |
| 4 | 6/2/2026 | View on SEC |
| 4 | 6/2/2026 | View on SEC |
| 4 | 6/2/2026 | View on SEC |
| 4 | 6/2/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INKT |
| Company Name | MiNK Therapeutics, Inc. |
| CIK | 1840229 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 212-994-8250 |